小方制药：1440万股限售股8月26日解禁

Group 1 - Company Xiaofang Pharmaceutical announced that 14.4 million restricted shares will be unlocked and listed for trading on August 26, 2025, accounting for 8.97% of the total share capital [1] - For the year 2024, Xiaofang Pharmaceutical's revenue composition is as follows: 99.93% from pharmaceutical preparations and 0.07% from other businesses [1] Group 2 - As of the latest report, Xiaofang Pharmaceutical has a market capitalization of 5.9 billion yuan [2]